-
Mashup Score: 7Microsoft Forms - 1 year(s) ago
Loading…
Source: forms.office.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
The Lynch Syndrome Center at Dana-Farber Cancer Institute is the largest and most comprehensive gastrointestinal cancer genetics group in the region that specializes in coordinating the care of people with Lynch syndrome.
Source: www.dana-farber.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
The @DanaFarber #LynchSyndrome Center is a unique multidisciplinary center that specializes in coordinating all aspects of care for individuals with Lynch Syndrome #LynchSyndromeAwarenessDay Contact info ➡️ https://t.co/7bNJTSLbIa https://t.co/BXPNbhTnR9
-
-
Mashup Score: 7Lynch Syndrome: Know your risk | Dana-Farber Cancer Institute - 1 year(s) ago
Dana-Farber’s Matt Yurgelun, MD, discusses Lynch Syndrome research and the challenges of a Lynch Syndrome diagnosis. Dana-Farber’s Lynch Syndrome Center offe…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
Today is #LynchSyndromeAawarenessDay! If you have a family history of #LynchSyndrome related cancers, especially at young ages, that might increase your risk of having Lynch syndrome. Know your family history! Know your risk! https://t.co/qx6dG7RTuK https://t.co/42unRNdqsF
-
-
Mashup Score: 1What is Lynch Syndrome? | Dana-Farber Cancer Institute - 1 year(s) ago
Visit: https://www.dana-farber.org/LynchSyndrome Matthew Yurgelun, MD, a gastrointestinal medical oncologist and Director of the Lynch Syndrome Center at Dan…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
Did you know that 1 out of 279 individuals has #LynchSyndrome - an inherited predisposition to various cancers? We think ~90% are unaware! If you have a personal/family history of colorectal, uterine, ovarian, stomach, and other cancers, consider testing! https://t.co/5f40F12oIk
-
-
Mashup Score: 5
Colorectal cancer (CRC) is one of the most prevalent tumours worldwide, with incidences (particularly in the context of early-onset cases) quickly inc…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @LValleResearch: BMPR2 as a novel predisposition gene for hereditary colorectal polypos... https://t.co/V7wrLrCNwE by @scastellvibel @l…
-
-
Mashup Score: 3I am walking for Dana-Farber patients - 1 year(s) ago
Together against cancer at the Jimmy Fund Walk
Source: Boston Marathon® Jimmy Fund WalkCategories: Latest Headlines, Oncologists1Tweet-
I just registered for the October 2023 #JimmyFundWalk to help raise critical funds for Dana-Farber's Lynch Syndrome Center Donate to Team #LynchSyndrome or, better yet, join the team! https://t.co/2mpy939IFn #JimmyFundWalk
-
-
Mashup Score: 1Please wait whilst we redirect you - 1 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet-
Full text of the article: https://t.co/ptGU3Y1eiM https://t.co/tmgG0weC4Q
-
-
Mashup Score: 1Clinical Factors Associated with Skin Neoplasms in Individuals with Lynch Syndrome in a Longitudinal Observational Cohort - 1 year(s) ago
While Lynch syndrome is known to increase risks of cutaneous neoplasia, the data from this analysis demonstrate that cutaneous neoplasms are the third most common malignancy identified in Lynch syndrome, after colorectal and endometrial cancers.Regular dermatologic surveillance should be considered for all individuals with Lynch syndrome.
Categories: Hem/Oncs, Latest HeadlinesTweet-
We’re excited to have our paper on cutaneous neoplasms #SkinCancer in #LynchSyndrome online at @JAADjournals - congrats to Dr Zhong for leading this important effort and thanks to collaborators @unoichi3 @SapnaSyngal @DanaFarber @bwhdermatology https://t.co/7RqeTMkBzL
-
-
Mashup Score: 0The 2022 debate not to miss! "Is it Time for Universal Germline Genetic Testing for All GI Cancers?" - 1 year(s) ago
On the occasion of the 2022 #PrevivorDay and #HereditaryCancerWeek, we’re delighted to bring you a podcast debate as part of the CGA-IGC 2022 Podcast Series – Episode 6. Hosted by Dr Michael Hall, the debate features Professor Heather Hampel and Dr Matthew Yurgelun going head to head over “Is it Time for Universal Germline Genetic Testing for All GI Cancers?” They debate the pros and cons of…
Source: CGA-IGCCategories: Hem/Oncs, Latest HeadlinesTweet-
For more on the question of universal germline testing in #CRC and other GI cancers #GI23: @CGAIGC podcast: https://t.co/AcvaJ1dLcZ
-
-
Mashup Score: 0Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for All GI Cancers? - 2 year(s) ago
Use of germline genetic testing among patients with cancer is increasing because of (1) the availability of multigene panel tests that include multiple cancer susceptibility genes in a single test, (2) decreased costs of these tests and improvements in insurance coverage, and (3) US Food and Drug Administration–approval of genotype-directed therapies such as poly(ADP-ribose) polymerase inhibitors…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
@Aiims1742 @HHampel1 @bhealdleach @Invitae @CKoptiuch @NCCN @evilarsan @skopetz Is it time, though? 🧐 I would argue it’s not so simple, and that high-level prevalence statistics don’t tell the whole story. https://t.co/5tTFzhKFAz
-
RT @Lynchsyndromirl: Your help is required. Please consider completing the survey. Link: https://t.co/N54zHKCjmy @Shotoole81 @thisisgo_ie…